Skip to content
healthcare.dev

LAMICTAL

NDC 0173-0526, lamotrigine, tablet, for suspension, from GlaxoSmithKline LLC.

Product NDC
0173-0526
Status
Listed
Labeler
GlaxoSmithKline LLC
Dosage form
TABLET, FOR SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA020764
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0173-0526 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LAMOTRIGINE5 mg/1

Pharmacologic classes

Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]; Dihydrofolate Reductase Inhibitors [MoA]; Mood Stabilizer [EPC]; Organic Cation Transporter 2 Inhibitors [MoA]

Package NDCNDC-11Package
0173-0526-0000173052600100 TABLET, FOR SUSPENSION in 1 BOTTLE (0173-0526-00)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d7e3572d-56fe-4727-2bb4-013ccca22678

Use it

Look up 0173-0526 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0173-0526 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0173-0526. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.